JAMDA
Volume 11, Issue 3 , Pages 211-221 , March 2010

Thrombotic Risk and Immobility in Residents of Long-Term Care Facilities

  • Barbara J. Zarowitz, PharmD, BCPS, FCCP, CGP, FASCP

      Affiliations

    • Omnicare, Inc, Livonia, MI
    • Corresponding Author InformationAddress correspondence to Barbara J. Zarowitz, PharmD, BCPS, FCCP, CGP, FASCP, Omnicare, Inc., 33510 Schoolcraft Road, Livonia, MI 48150.
    • ,
  • Eric Tangalos, MD

      Affiliations

    • Mayo Clinic, Rochester, MN
    • ,
  • Allen Lefkovitz, PharmD, CGP, FASCP

      Affiliations

    • Omnicare, Inc, Livonia, MI
    • ,
  • Henry Bussey, PharmD, FCCP

      Affiliations

    • College of Pharmacy, University of Texas at Austin, Austin, TX
    • ,
  • Steven Deitelzweig, MD

      Affiliations

    • Department of Hospital Medicine, Ochsner Medical Center and Tulane University Medical College, New Orleans, LA
    • ,
  • Edith Nutescu, PharmD

      Affiliations

    • School of Pharmacy, University of Illinois, Chicago, IL
    • ,
  • Terrence O'Shea, PharmD, CGP, FASCP

      Affiliations

    • Omnicare, Inc, Livonia, MI
    • ,
  • Barbara Resnick, RNP

      Affiliations

    • University of Maryland, Baltimore, MD
    • ,
  • Arthur Wheeler, MD

      Affiliations

    • Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN

References 

  1. Goldhaber SZ. Preventing pulmonary embolism and deep vein thrombosis: A call to action for vascular medicine specialists. Thromb Haemost. 2007;5:1607–1608
  2. Heit JA, Cohen AT. Anderson FAJ on behalf of the VTE Impact Assessment Group. Estimated annual number of incident and recurrent, non-fatal venous thromboembolism (VTE) events in the US. ASH Annual Meeting Abstracts. 2005;106:910
  3. Anderson FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151:933–938
  4. Heit JA. Venous thromboembolism: Disease burden, outcomes and risk factors. J Thromb Haemost. 2005;3:1611–1617
  5. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107:14–18
  6. Wan H, Sengupta M, Velkoff VA, DeBarros KA. US Census Bureau, Current Population Reports, P23–209, 65+ in the United States: 2005. Washington, DC: US Government Printing Office; 2005;Available at http://www.census.gov/prod/2006pubs/p23-209.pdfAccessed March 4, 2009
  7. Leibson CL, Petterson TM, Bailey KR, et al. Risk factors for venous thromboembolism in nursing home residents. Mayo Clin Proc. 2008;83:151–157
  8. Gomes JP, Shaheen WH, Truong SV, et al. Incidence of venous thromboembolic events among nursing home residents. J Gen Intern Med. 2003;18:934–936
  9. Weill-Engerer S, Meaume S, Lahlou A, et al. Risk factors for deep vein thrombosis in inpatients aged 65 and older: A case-control multicenter study. J Am Geriatr Soc. 2004;52:1299–1304
  10. Geerts WH, Bergquvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133:381S–453SAvailable at http://chestjournal.org/cgi/content/abstract/133/6_suppl/381SAccessed August 10, 2009
  11. Couturaud F, Lacut K, Leroyer C, Mottier D. Assessment of the risk and prophylactic treatment of venous thromboembolism in the elderly. Pathophysiol Haemost Thromb. 2003/2004;33:362–365
  12. Jacobs IG. Prophylactic anticoagulation for venous thromboembolic disease in geriatric patients. J Am Geriatr Soc. 2003;51:1472–1478
  13. Bosson JL, Labarere J, Barrellier MT, et al. [Practice guidelines for the prevention of venous thromboembolism in elderly patients hospitalized in subacute care and rehabilitation facilities.]. J Mal Vasc. 2003;28:209–218French
  14. Yeznach Wick J. Treat VTE in long-term care. Caring for the Ages. 2004;5:38–48
  15. Sloane PD, Gruber-Baldini AL, Zimmerman S, et al. Medication undertreatment in assisted living facilities. Arch Intern Med. 2004;164:2031–2037
  16. Amin A, Stemkowski S, Lin J, Yang G. Thromboprophylaxis rates in US medical centers: Success or failure?. J Thromb Haemost. 2007;5:1610–1616
  17. Goldhaber SZ, Tapson VF. A prospective registry of 5,441 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol. 2004;93:259–262
  18. Kucher N, Tapson VF, Goldhaber SZ. DVT FREE Steering Committee. Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients. Thromb Haemost. 2005;93:494–498
  19. Tapson VF, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest. 2007;132:936–945
  20. Piazza G, Seddighzadeh A, Goldhaber SZ, et al. Heart failure in patients with deep vein thrombosis. Am J Cardiol. 2008;101:1056–1059
  21. Shetty R, Seddighzadeh A, Piazza G, et al. Chronic obstructive pulmonary disease and deep vein thrombosis: A prevalent combination. J Thromb Thrombolysis. 2008;26:35–40
  22. Semana MM, Dahl LE, Quinlan DJ, et al. Quantification of risk factors for venous thromboembolism: A preliminary study for the development of a risk assessment tool. Haematologica. 2003;88:1410–1421
  23. Arcelus JI, Caprini JA, Monreal M, et al. The management and outcome of acute venous thromboembolism: A prospective registry including 4011 patients. J Vasc Surg:916-922, and algorithm available at: http://www.venousdisease.com/riskfactors.html. Accessed December 10, 2009.
  24. Van Tulder M, Furlan A, Bombardier C, Bouter L. Editorial Board of the Cochrane Collaboration Back Review Group. Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine. 2003;28:1290–1299
  25. Dalkey N, Brown B, Cochran S. The Delphi Method, III: Use of self ratings to improve group estimates. Santa Monica, CA: Rand Corporation; November 1969;Publication RM-6115-PR
  26. Grady D, Wenger NK, Herringto D, et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease (HERS). Ann Intern Med. 2000;132:689–696
  27. Hull RD. Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility (EXCLAIM). J Thromb Thrombolysis. 2006;22:31–36
  28. PREVENT. Investigators. Rationale and design of LMWH in preventing clinically important DVT in medical patients. PREVENT study. Vasc Med. 2002;7:269–273
  29. Ray JG, Kearon C, Yi Q, et al. Homocysteine-lowering therapy and risk for venous thromboembolism. Ann Intern Med. 2007;146:761–767
  30. Ageno W, Prandoni P, Romualdi E, et al. The metabolic syndrome and the risk of venous thrombosis: A case-control study. J Thromb Haemost. 2006;4:1914–1918
  31. Aguilar C, Martinez A, Martinez A, et al. Diagnostic value of D-dimer in patients with a moderate pretest probability of DVT. Br J Haematol. 2002;118:275–277
  32. Alikhan R, Cohen AT, Combe S, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness. Arch Intern Med. 2004;164:963–968
  33. Baglin T, Palmer CR, Luddington R, et al. Unprovoked recurrent venous thrombosis: Prediction by D-dimer and clinical risk factors. J Thromb Haemost. 2008;6:577–582
  34. Baglin T, Luddington R, Brown K, et al. High risk of recurrent venous thromboembolism in men. J Thromb Haemost. 2004;2:2152–2155
  35. Bjørnarå BT, Gudmundsen TE, Dahl OE. Frequency and timing of clinical venous thromboembolism after major joint surgery. J Bone Joint Surg [Br]. 2006;88-B:386–391
  36. Blom JW, Vanderschoot JPM, Oostindier MJ, et al. Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: Results of a record linkage study. J Thromb Haemost. 2006;4:529–535
  37. Bosson JL, Labarere J, Sevestre MA, et al. Deep vein thrombosis in elderly patients hospitalized in subacute care facilities. Arch Intern Med. 2003;163:2613–2618
  38. Canonico M, Oger E, Conard J, et al. Obesity and risk of venous thromboembolism among postmenopausal women (The ESTHER Study). J Thromb Haemost. 2006;4:1259–1265
  39. Cosmi B, Legnani C, Cini M, et al. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis. Thromb Haemost. 2005;94:969–974
  40. Curb JD, Prentice RL, Bray PF, et al. Venous thrombosis and conjugated equine estrogen in women without a uterus (WHI). Arch Intern Med. 2006;166:772–780
  41. Cushman M, Folsom AR, Wang L, et al. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood. 2003;101:1243–1248
  42. Douketis JD, Crowther MA, Foster GA, et al. Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?. Am J Med. 2001;110:515–519
  43. Edelsberg J, Hagiwara M, Taneja C, et al. Risk of venous thromboembolism among hospitalized medically ill patients. Am J Health-Syst Pharm. 2006;63:S16–S22
  44. Folsom AR, Boland LL, Cushman M, et al. Frailty and risk of venous thromboembolism in older adults. J Gerontol. 2007;62A:79–82
  45. Gallerani M, Boari B, de Toma D, et al. Seasonal variation in the occurrence of deep vein thrombosis. Med Sci Monit. 2004;10:CR191–CR196
  46. Gangireddy C, Rectenwald JR, Upchurch GR, et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg. 2007;45:335–342
  47. Gatt ME, Paltiel O, Bursztyn M. Is prolonged immobilization a risk factor for symptomatic venous thromboembolism in elderly bedridden patients?. Thromb Haemost. 2004;91:538–543
  48. Haas SK, Hach-Wunderle V, Mader FH, et al. An evaluation of venous thromboembolism risk in acutely 111 medical patients immobilized at home: The AT-HOME Study. Clin Appl Thromb Hemost. 2007;13:7–13
  49. Hansson PO, Sörbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis. Arch Intern Med. 2000;160:769–774
  50. Heit JA, Mohr DN, Silverstein MD, et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism. Arch Intern Med. 2000;160:761–768
  51. Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost. 2001;86:452–463
  52. Howell MD, Geraci JM, Knowlton AA. Congestive heart failure and outpatient risk of venous thromboembolism. J Clin Epidemiol. 2001;54:810–816
  53. Huerta C, Johansson S, Wallander MA, et al. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the UK. Arch Intern Med. 2007;167:935–943
  54. Lawall H, Hoffmanns W, Hoffmanns P, et al. Prevalence of deep vein thrombosis in non-surgical patients at hospital admission. Thromb Haemost. 2007;98:765–770
  55. Mantilla CB, Horlocker TT, Schroeder DR, et al. Risk factors for clinically relevant pulmonary embolism and deep vein thrombosis in patients undergoing primary hip or knee arthroplasty. Anesthesiol. 2003;99:552–560
  56. Palareti G, Legnani C, Cosmi B, et al. Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence. J Thromb Haemost. 2005;3:955–961
  57. Palareti G, Legnani C, Cosmi B, et al. Risk of venous thromboembolism recurrence. Thromb Haemost. 2002;87:7–12
  58. Piazza G, Seddighzadeh A, Goldhaber SZ. Deep vein thrombosis in the elderly. Clin Ap Thromb Hemost. 2008;14:393–398
  59. Proctor MC, Wainess RM, Henke PK, et al. Venous thromboembolism: Regional differences in the nationwide inpatient sample, 1993 to 2000. Vascular. 2004;12:374–380
  60. Ray JG, Mamdani M, Tsuyuki RT, et al. Use of statins and the subsequent development of DVT. Arch Intern Med. 2001;161:1405–1410
  61. Ray JG, Mamdani M, Yeo EL. Antipsychotic and antidepressant drug use in the elderly and the risk of VTE. Thromb Haemost. 2002;88:205–209
  62. Sellier E, Labarere J, Sevestre MA, et al. Risk factors for deep vein thrombosis in older patients: a multicenter study with systematic compression ultrasonography in postacute care facilities in France. J Am Geriatr Soc. 2008;56:224–230
  63. Smeeth L, Cook C, Thomas S, et al. Risk of DVT and PE after acute infection in a community setting. Lancet. 2006;367:1075–1079
  64. Spencer FA, Emery C, Lessard D, et al. Upper extremity deep vein thrombosis: A community-based perspective. Am J Med. 2007;120:678–684
  65. van Stralen KJ, Doggen CJM, Lumley T, et al. The relationship between exercise and risk of VT in elderly people. J Am Geriatr Soc. 2008;56:517–522
  66. White RH, Zhou H, Murin S, et al. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost. 2005;93:298–305
  67. Zakai NA, Wright J, Cushman M. Risk factors for venous thromboembolism in medical inpatients: Validation of a thrombosis risk score. J Thromb Haemost. 2004;2:2156–2161
  68. Bosson JL. A prospective observational study of a cohort of outpatients with an acute medical event and reduced mobility. J Int Med. 2006;260:168–176
  69. Cohen AT, Turpie AGG, Leizorovicz A, et al. Thromboprophylaxis with dalteparin in medical patients: Which patients benefit?. Vascular Medicine. 2007;12:123–128
  70. Duggan C. Inherited and acquired risk factors for VTE disease among women taking tamoxifen to prevent breast cancer. J Clin Oncol. 2003;21:3588–3593
  71. Montreal M. Fatal PE and fatal bleeding in cancer patients with VTE; findings from RIETE registry. J Thromb Haemost. 2006;4:1950–1956
  72. Steen HE. Thrombosis associated with physical restraints. Acta Psychiatr Scand. 2001;103:73–76
  73. De Freitas GR, Nagayama M. Deep venous thrombosis after intracerebral hemorrhage, gender and ethnicity: A challenge for therapeutic approaches. Cerebrovasc Dis. 2009;27:320–321
  74. Katz S, Akpom CA. 12. Index of ADL. Med Care. 1976;14:116–118
  75. Podsiadlo D, Richardson S. The Timed “Up & Go”: A test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142–148
  76. Valderrama A, Del Castrillo J, DiazGranados CA, et al. Deep vein thrombosis in chronically bedridden elderly individuals. J Am Geriatr Soc. 2006;54:866–867
  77. Giannelli SV, Patel KV, Windham GB, et al. Magnitude of underascertainment of impaired kidney function in older adults with normal serum creatinine. J Am Geriatr Soc. 2007;55:816–823
  78. Schulman S, Beyth RJ, Kearon C, Levine MN. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-based clinical practice guidelines. (8th Edition) Chest. 2008;133:257S–298S
  79. Hirsh J, Guyatt G, Albers GW, et al. Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (8th Edition) Chest. 2008;133:110S–112S

 The literature evaluation, on-site meeting, travel to the meeting, and biostatistical support were supported by an investigator-initiated grant (DCLB-547377.1) from Sanofi-Aventis Pharmaceuticals, USA.

PII: S1525-8610(09)00409-5

doi: 10.1016/j.jamda.2009.11.006

JAMDA
Volume 11, Issue 3 , Pages 211-221 , March 2010

Article Tools

* Image Usage & Resolution